Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly LB03002 (somatropin) in adults with growth hormone deficiency
2005-000384-26Phase 3Completed
- Sponsor
- LG Life Sciences
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in growth hormone deficiency (GHD) comparing LB03002 weekly with Placebo weekly (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jun 2005; status: completed.
02
Drugs
Eutropin Plus
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2005-000384-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000384-26.